PYC Therapeutics (ASX: PYC)
Biotechnology Research • 
San Francisco, California, United States • 51-100 Employees
Company overview
| Headquarters | San Francisco, California, United States |
| Phone number | +161861510992 |
| Website | |
| Keywords | RNA, Neurodegenerative Disease, Retinitis Pigmentosa, Retinal Disease, Rare Disease, Cell-Penetrating Peptides |
| Founded | 2005 |
| Employees | 51-100 |
| Socials |
Key Contacts at PYC Therapeutics (ASX: PYC)
Sebastian Rauschert
Director Of Bioinformatics & Data Analytics
Arunabha Chakma
Director Project Management
Subrata Das
Senior Director, Chemistry, Manufacturing, And Controls. Head Of Drug Product Development
Rohan Hockings
Executive Director
Maria Kerfoot
Director Of Nonclinical Development
PYC Therapeutics (ASX: PYC) Email Formats
PYC Therapeutics (ASX: PYC) uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@pyctx.com), used 69% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@pyctx.com | 69% |
{first initial}.{last name} | j.doe@pyctx.com | 29.3% |
{first initial}.{second initial}{last name} | j.odoe@pyctx.com | 1.7% |
About PYC Therapeutics (ASX: PYC)
PYC Therapeutics (ASX: PYC) is a clinical stage biotechnology company pioneering a new generation of RNA therapeutics for genetic diseases. It works by combining two complementary platforms: RNA-based drug design and PYC’s proprietary drug delivery technology. PYC's library of naturally derived cell penetrating peptides provide its delivery platform to overcome the major challenges of RNA therapeutics - getting into the target cell. PYC believes its PPMO (Peptide conjugated Phosphorodiamidate Morpholino Oligomer) technology enables a safer and more effective RNA therapeutic to address the underlying drivers of a range of genetic diseases for which no treatment solutions exist today. The Company is leveraging its leading-edge science to develop a pipeline of novel therapies including two programs focused on inherited eye diseases and preclinical discovery efforts focused on neurodegenerative diseases. PYC’s discovery and laboratory operations are located in Australia, and the Company’s preclinical and clinical operations are based in San Fransisco California.
PYC Therapeutics (ASX: PYC) revenue & valuation
| Annual revenue | $6,416,625 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $20,600,000 |
| Total funding | $26,300,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
PYC Therapeutics (ASX: PYC) has 31 employees across 8 departments.
Departments
Number of employees
Funding Data
Explore PYC Therapeutics (ASX: PYC)'s funding history, including investment rounds, total capital raised, and key backers.
PYC Therapeutics (ASX: PYC) Tech Stack
Discover the technologies and tools that power PYC Therapeutics (ASX: PYC)'s digital infrastructure, from frameworks to analytics platforms.
Security
Digital asset management
Security
Caching
JavaScript libraries
JavaScript libraries
Maps
JavaScript libraries
JavaScript libraries
CDN
India
CanadaFrequently asked questions
4.8
40,000 users
